ADMA Biologics, Inc. (ADMA)
10.35
+0.02
(+0.19%)
USD |
NASDAQ |
Oct 09, 16:00
10.35
0.00 (0.00%)
After-Hours: 16:10
ADMA Biologics 30-Day Average Daily Volume : 2.913M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 2.913M |
| October 07, 2026 | 2.829M |
| October 06, 2026 | 2.777M |
| October 05, 2026 | 2.772M |
| October 02, 2026 | 2.704M |
| October 01, 2026 | 2.684M |
| September 30, 2026 | 2.641M |
| September 29, 2026 | 2.597M |
| September 28, 2026 | 2.532M |
| September 25, 2026 | 2.456M |
| September 24, 2026 | 2.441M |
| September 23, 2026 | 2.419M |
| September 22, 2026 | 2.417M |
| September 21, 2026 | 2.389M |
| September 18, 2026 | 2.404M |
| September 17, 2026 | 2.211M |
| September 16, 2026 | 2.267M |
| September 15, 2026 | 2.268M |
| September 14, 2026 | 2.235M |
| September 11, 2026 | 2.186M |
| September 10, 2026 | 2.154M |
| September 09, 2026 | 2.133M |
| September 08, 2026 | 2.126M |
| September 04, 2026 | 2.139M |
| September 03, 2026 | 2.170M |
| Date | Value |
|---|---|
| September 02, 2026 | 2.213M |
| September 01, 2026 | 2.213M |
| August 31, 2026 | 2.240M |
| August 28, 2026 | 2.265M |
| August 27, 2026 | 2.390M |
| August 26, 2026 | 2.433M |
| August 25, 2026 | 2.459M |
| August 24, 2026 | 2.500M |
| August 21, 2026 | 2.530M |
| August 20, 2026 | 2.559M |
| August 19, 2026 | 2.553M |
| August 18, 2026 | 2.539M |
| August 17, 2026 | 2.571M |
| August 14, 2026 | 2.609M |
| August 13, 2026 | 2.711M |
| August 12, 2026 | 2.709M |
| August 11, 2026 | 2.737M |
| August 10, 2026 | 2.796M |
| August 07, 2026 | 2.931M |
| August 06, 2026 | 2.940M |
| August 05, 2026 | 2.859M |
| August 04, 2026 | 2.832M |
| August 03, 2026 | 2.862M |
| July 31, 2026 | 3.073M |
| July 30, 2026 | 3.127M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Vericel Corp. | 530692.3 |
| BioMarin Pharmaceutical, Inc. | 2.072M |
| Emergent BioSolutions, Inc. | 1.179M |
| Exelixis, Inc. | 2.159M |
| Akebia Therapeutics, Inc. | 7.543M |